Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 383,357Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Dr. Reddy's Laboratories

02 2Actavis Inc

03 4Alembic Pharmaceuticals Limited

04 4ENDO OPERATIONS

05 4Gebro Pharma

06 4Ideogen AG

07 1ORIFARM GROUP AS

08 4OrPha Swiss

09 4Sandoz B2B

10 4Teva Pharmaceutical Industries

11 33United Therapeutics

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 5MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

09

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 0.125MG

Packaging :

Approval Date :

Application Number : 208906

Regulatory Info :

Registration Country : USA

blank

10

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2017-11-30

Application Number : 203649

Regulatory Info : RX

Registration Country : USA

blank

11

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date : 2017-11-30

Application Number : 203649

Regulatory Info : RX

Registration Country : USA

blank

12

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 5MG/ML

Packaging :

Approval Date : 2017-11-30

Application Number : 203649

Regulatory Info : RX

Registration Country : USA

blank

13

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2017-11-30

Application Number : 203649

Regulatory Info : RX

Registration Country : USA

blank

14

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2019-09-26

Application Number : 206648

Regulatory Info : RX

Registration Country : USA

blank

15

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date : 2019-09-26

Application Number : 206648

Regulatory Info : RX

Registration Country : USA

blank

16

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 5MG/ML

Packaging :

Approval Date : 2019-09-26

Application Number : 206648

Regulatory Info : RX

Registration Country : USA

blank

17

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2019-09-26

Application Number : 206648

Regulatory Info : RX

Registration Country : USA

blank

18

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

19

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

20

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 5MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

21

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

22

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 20MG/ML

Packaging :

Approval Date : 2021-07-30

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

23

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 0.1MG/ML

Packaging :

Approval Date : 2023-09-28

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

24

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date : 2023-09-28

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

25

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 0.4MG/ML

Packaging :

Approval Date : 2023-09-28

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

26

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : TYVASO

Dosage Form : SOLUTION;INHALATION

Dosage Strength : 0.6MG/ML

Packaging :

Approval Date : 2009-07-30

Application Number : 22387

Regulatory Info : RX

Registration Country : USA

blank

27

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 20MG/20ML (1MG/ML)

Packaging :

Approval Date : 2018-07-30

Application Number : 208276

Regulatory Info : DISCN

Registration Country : USA

blank

28

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 50MG/20ML (2.5MG/ML)

Packaging :

Approval Date : 2018-07-30

Application Number : 208276

Regulatory Info : DISCN

Registration Country : USA

blank

29

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 100MG/20ML (5MG/ML)

Packaging :

Approval Date : 2018-07-30

Application Number : 208276

Regulatory Info : DISCN

Registration Country : USA

blank

30

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 200MG/20ML (10MG/ML)

Packaging :

Approval Date : 2018-07-30

Application Number : 208276

Regulatory Info : DISCN

Registration Country : USA

blank